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Background
Stevens-Johnson syndrome (SJS) and toxic epidermal
necrolysis (TEN) are life-threatening hypersensitivity
reactions to medications characterized by keratinocyte
apoptosis, the formation of subepidermal blisters, and
skin detachment. Cytotoxic lymphocytes including CTLs
and NK cells seem to be the main effectors of keratino-
cyte killing. Natural killer cytotoxic activity is regulated
through the balance of activating and inhibitory signals
delivered by innate receptors, some of which recognize
HLA class I antigens. Among them, inhibitory CD94/
NKG2A and activating CD94/NKG2C receptors are spe-
cific for the non-classical HLA class Ib molecule HLA-E,
and are expressed not only in NK cells but also in subsets
of T lymphocytes. We have previously reported that the
activating receptor CD94/NKG2C is overexpressed in
lymphocytes from SJS/TEN patients resulting in net acti-
vation and lysis of HLA-E+ targets. Moreover, HLA-E
was found to be overexpressed in affected skin, and in
agreement with previous reports showing soluble HLA-E
(sHLA-E) released in response to cell activation, we
found sHLA-E in blister fluids from SJS/TEN patients.
Objective
To explore the impact of sHLA-E in the functional
capacities of cytotoxic lymphocytes.
Methods
Conditioned media enriched in sHLA-E or sHLA-B27
(used as a negative control) were prepared and assayed
in 51Cr release assays using purified CD94/NKG2A+ or
CD94/NKG2C+ primary human NK cells as effector
cells. Production of IFN- was also investigated. Western
blot was performed to study the phosphorylation status
of the signal transducing molecule DAP12.
Results
The cytotoxic activity and the production of IFN- by
NKG2C+ NK cells were significantly increased in the pre-
sence of sHLA-E. Moreover, increased phosphorylation of
DAP12 was detected. In addition, blister fluids from SJS/
TEN patients, were also able to specifically increase the
cytotoxic activity of NKG2C+ NK cells, and this effect was
reverted in the presence of blocking antibodies against
HLA-E.
Conclusion
sHLA-E acts as an agonist of the activating receptor
CD94/NKG2C. The results suggest that sHLA-E mole-
cules in blister fluids may contribute to the massive killing
of keratinocytes in SJS/TEN patients by enhancing the
activity of NKG2C+ cytotoxic lymphocytes.
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